MAPK8IP2 and invasive breast carcinoma: The results showed significantly higher expression of MAPK8IP2 in 15 types of human cancer, including prostate adenocarcinoma (PRAD), breast invasive carcinoma (BRCA), and bladder urothelial carcinoma (BLCA) (cancer tissues vs. normal tissues).